ALB and Hypocalcemia: The TEAE more frequently reported among patients who were more severely ill in the pivotal trial might be attributed to the disease itself and include back pain, increase in blood potassium, anaemia, decrease in blood albumin, chest pain, cough, pyrexia, or hypocalcaemia.